That is definitely a point of concern, and given there are more escrowed shares waiting in the wings, there will be lot of selling pressure while holders get out with any profit they can take since the IPO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025